These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38409249)

  • 1. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling.
    Cai Z; Li W; Hager S; Wilson JL; Afjehi-Sadat L; Heiss EH; Weichhart T; Heffeter P; Weckwerth W
    Cell Mol Immunol; 2024 May; 21(5):448-465. PubMed ID: 38409249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse Data-Driven Modeling and Multiomics Analysis Reveals Phgdh as a Metabolic Checkpoint of Macrophage Polarization and Proliferation.
    Wilson JL; Nägele T; Linke M; Demel F; Fritsch SD; Mayr HK; Cai Z; Katholnig K; Sun X; Fragner L; Miller A; Haschemi A; Popa A; Bergthaler A; Hengstschläger M; Weichhart T; Weckwerth W
    Cell Rep; 2020 Feb; 30(5):1542-1552.e7. PubMed ID: 32023468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition.
    Rinaldi G; Pranzini E; Van Elsen J; Broekaert D; Funk CM; Planque M; Doglioni G; Altea-Manzano P; Rossi M; Geldhof V; Teoh ST; Ross C; Hunter KW; Lunt SY; Grünewald TGP; Fendt SM
    Mol Cell; 2021 Jan; 81(2):386-397.e7. PubMed ID: 33340488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma.
    Rathore R; Caldwell KE; Schutt C; Brashears CB; Prudner BC; Ehrhardt WR; Leung CH; Lin H; Daw NC; Beird HC; Giles A; Wang WL; Lazar AJ; Chrisinger JSA; Livingston JA; Van Tine BA
    Cell Rep; 2021 Jan; 34(4):108678. PubMed ID: 33503424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine synthesis pathway enzyme PHGDH is critical for muscle cell biomass, anabolic metabolism, and mTORC1 signaling.
    Mäntyselkä S; Kolari K; Baumert P; Ylä-Outinen L; Kuikka L; Lahtonen S; Permi P; Wackerhage H; Kalenius E; Kivelä R; Hulmi JJ
    Am J Physiol Endocrinol Metab; 2024 Jan; 326(1):E73-E91. PubMed ID: 37991454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 7. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the PD-L1/PD-1 axis between TAMs and T lymphocytes.
    Bi S; Huang W; Chen S; Huang C; Li C; Guo Z; Yang J; Zhu J; Song L; Yu R
    Int J Biol Macromol; 2020 May; 150():261-280. PubMed ID: 32044366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.
    Possemato R; Marks KM; Shaul YD; Pacold ME; Kim D; Birsoy K; Sethumadhavan S; Woo HK; Jang HG; Jha AK; Chen WW; Barrett FG; Stransky N; Tsun ZY; Cowley GS; Barretina J; Kalaany NY; Hsu PP; Ottina K; Chan AM; Yuan B; Garraway LA; Root DE; Mino-Kenudson M; Brachtel EF; Driggers EM; Sabatini DM
    Nature; 2011 Aug; 476(7360):346-50. PubMed ID: 21760589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
    Ma X; Li B; Liu J; Fu Y; Luo Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer.
    Luo Q; Zheng N; Jiang L; Wang T; Zhang P; Liu Y; Zheng P; Wang W; Xie G; Chen L; Li D; Dong P; Yuan X; Shen L
    Cancer Sci; 2020 Nov; 111(11):4000-4011. PubMed ID: 32798273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
    Liu J; Zhang C; Wu H; Sun XX; Li Y; Huang S; Yue X; Lu SE; Shen Z; Su X; White E; Haffty BG; Hu W; Feng Z
    J Clin Invest; 2020 Jun; 130(6):3253-3269. PubMed ID: 32478681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of L2HGDH-mediated S-2HG catabolism orchestrates macrophage polarization to elicit antitumor immunity.
    Feng S; Wang D; Jin Y; Huang S; Liang T; Sun W; Du X; Zhuo L; Shan C; Zhang W; Jing T; Zhao S; Hong R; You L; Liu G; Chen L; Ye D; Li X; Yang Y
    Cell Rep; 2024 Jun; 43(6):114300. PubMed ID: 38829739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate.
    Fan J; Teng X; Liu L; Mattaini KR; Looper RE; Vander Heiden MG; Rabinowitz JD
    ACS Chem Biol; 2015 Feb; 10(2):510-6. PubMed ID: 25406093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy.
    Zhang D; Li AM; Hu G; Huang M; Yang F; Zhang L; Wellen KE; Xu X; Conn CS; Zou W; Kahn M; Rhoades SD; Weljie AM; Fuchs SY; Amankulor N; Yoshor D; Ye J; Koumenis C; Gong Y; Fan Y
    Cell Metab; 2023 Mar; 35(3):517-534.e8. PubMed ID: 36804058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer.
    Zhu H; Yu H; Zhou H; Zhu W; Wang X
    Adv Sci (Weinh); 2023 Jun; 10(17):e2205818. PubMed ID: 37078828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer.
    Yamamoto T; Hayashida T; Masugi Y; Oshikawa K; Hayakawa N; Itoh M; Nishime C; Suzuki M; Nagayama A; Kawai Y; Hishiki T; Matsuura T; Naito Y; Kubo A; Yamamoto A; Yoshioka Y; Kurahori T; Nagasaka M; Takizawa M; Takano N; Kawakami K; Sakamoto M; Wakui M; Yamamoto T; Kitagawa Y; Kabe Y; Horisawa K; Suzuki A; Matsumoto M; Suematsu M
    Cancer Res; 2024 Apr; 84(7):1065-1083. PubMed ID: 38383964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.